文献速递头颈外科

欧洲癌症研究与治疗组织头颈癌生活质量模块EORTC QLQ-HN43修订版的国际验证:IV期研究

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
PubMed 文献 · Head Neck · 2019-01-12

本研究纳入来自18个国家的812例头颈癌患者,对EORTC QLQ-HN43进行国际验证。组1在治疗前及治疗后3、6个月完成问卷,组2(幸存者)用于评估重测信度。结果显示10/12个多条目量表Cronbach's α>0.70,所有标准化因子负荷>0.40,除两个量表外ICC均>0.70,19个量表中有17个已知组差异>10分,18个量表对变化的敏感性充分,支持该模块的信度和效度。

要点

  • EORTC QLQ-HN43在18国812例头颈癌患者中验证,10/12个多条目量表Cronbach's α>0.70。
  • 所有标准化因子负荷>0.40,除两个量表外ICC均>0.70。
  • 19个量表中有17个已知组差异>10分,18个量表对变化的敏感性充分。

核心结论

  • 证据支持EORTC QLQ-HN43作为生活质量测量工具的信度和效度。

研究设计与样本

  • IV期国际验证研究,纳入来自18个国家的812例头颈癌患者。
  • 组1在治疗前及治疗后3、6个月完成问卷;组2为幸存者,用于评估重测信度。

主要发现

  • 12个多条目量表中有10个Cronbach's α>0.70。
  • 所有标准化因子负荷均>0.40。
  • 除两个量表外,所有量表ICC均>0.70。
  • 19个量表中有17个已知组间评分差异>10分。
  • 18个量表对变化的敏感性充分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We validated the new European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43). METHODS: We enrolled 812 patients with head and neck cancer from 18 countries. Group 1 completed the questionnaire before therapy, and 3 and 6 months later. In group 2 (survivors), we determined test-retest reliability using intraclass correlation coefficients (ICC). Internal consistency was assessed using Cronbach's Alpha, the scale structure with confirmatory factor analysis, and discriminant validity with known-group comparisons. RESULTS: Cronbach's alpha was >0.70 in 10 of the 12 multi-item scales. All standardized factor loadings exceeded 0.40. The ICC was >0.70 in all but two scales. Differences in scale scores between known-groups were >10 points in 17 of the 19 scales. Sensitivity to change was found to be sufficient in 18 scales. CONCLUSIONS: Evidence supports the reliability and validity of the EORTC QLQ-HN43 as a measure of quality of life.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Singer S, Amdal CD, Hammerlid E, et al. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Head Neck. 2019. PMID: 30636188. doi:10.1002/hed.25609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。